Navigation Links
B. Riley Exclusive Financial Advisor to Mirth Corporation in Connection with its Corporate Sale to Quality Systems, Inc.
Date:9/19/2013

LOS ANGELES, Sept. 19, 2013 /PRNewswire/ -- B. Riley & Co., LLC, ("B. Riley") www.brileyco.com, a leading independent investment bank, has served as exclusive financial advisor to Mirth Corporation in its acquisition by Quality Systems, Inc. (NASDAQ: QSII).  Transaction consideration consisted of both cash and QSII securities. 

(Logo: http://photos.prnewswire.com/prnh/20130510/LA11405LOGO)

B. Riley devised the acquisition thesis, initiated, structured and assisted in the negotiations on behalf of privately-held Mirth, a healthcare IT company, and its shareholders.  The B. Riley transaction team was led by Senior Managing Director Greg Presson and Managing Director Adam Little, both based in the firm's Orange County office. 

"The culmination of this corporate sale was a direct result of working collaboratively with B. Riley for the last several years.  They were instrumental in helping us define and chart a path to liquidity, which also included identifying numerous strategic buyers that were ultimately attracted to the Company's proprietary healthcare IT technology platform and suite of products and services," said Jon Teichrow, President and Co-Founder of Mirth.  

"Mirth's selection of B. Riley to represent us was based on the firm's keen perspectives and activity level within the dynamic healthcare IT industry.  The firm is also recognized for its ability to leverage its client's technology offerings and customer value propositions to position them for maximum valuation through the M&A process.  Their skillful management of the entire corporate sale process was exceptional," said Sam Sippl, Chief Financial Officer for Mirth.

"B. Riley's active M&A involvement in the healthcare and medical device sectors allows us to continually gain valuable insight into which strategic corporate buyers and private equity groups are actively pursuing acquisitions of growth oriented companies similar to our client," said Mr. Presson.

"The completion of this transaction continues to underscore our commitment to the healthcare and health IT sectors for those companies seeking proven and experienced corporate sale representations and timely capital market access," added Mr. Little.      

Founded by Jon Teichrow, Gary Teichrow and Andy Thorson, Mirth is headquartered in Costa Mesa, California. It is an emerging global leader in health information technology that helps clients achieve interoperability across silo-structured data systems.  Mirth's solutions are used daily by thousands of health professionals and institutions worldwide to streamline care management processes and to securely exchange health information across enterprises, communities and broad geographies.  For more information, visit www.mirthcorp.com.    

Irvine, California based Quality Systems, Inc. and its NextGen Healthcare subsidiary develop and market computer-based practice management, electronic health records and revenue cycle management applications as well as connectivity products and services for medical and dental group practices and small hospitals.  Visit www.qsii.com and www.nextgen.com for additional information.

About B. Riley & Co, LLC.
B. Riley & Co. is a leading independent investment bank which provides a full array of corporate finance, research, sales, trading and otcqx dad services to corporate, institutional and high net worth individual clients. Investment banking services include merger and acquisitions advisory to public and private middle market companies, initial and secondary public offerings and institutional private placements. Its Corporate Governance Advisory Services Group is engaged by both companies and investors to help maximize value for shareholders. The firm is recognized for its distinguished Equity Research. Founded in 1997, B. Riley is headquartered in Los Angeles and maintains offices in Newport Beach, San Francisco, Boston and New York.  It is a member of FINRA and SIPC. For more information, please visit www.brileyco.com


'/>"/>
SOURCE B. Riley & Co., LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Heska Corporation to Present at the 14th Annual B. Riley & Co. Investor Conference
2. B. Riley Revises Timing of STAAR Surgical Presentation at Investor Conference
3. Heska to Present at B. Riley Investor Conference
4. Debiopharm Group and TCG Lifesciences Ltd. Enter into an Exclusive Research Agreement to Develop a Novel Class of Antibiotics, a New Strategic Therapeutic Area for Debiopharm
5. Sanofi US and POZEN Sign Exclusive License Agreement for the Commercialization of PA8140/PA32540 Tablets in the U.S.
6. Eisai Inc. Announces Non-Exclusive Licensing Agreement with Generic Drug Manufacturer to Provide Generic Version of donepezil HCl 23 mg
7. Digirad Signs Exclusive International Distribution Agreement with Dilon Diagnostics
8. GUARDaHEART to Host Exclusive Event focused on Targeting Heart Disease in Celebration of the World Heart Day Mission
9. BSI Offers Medical Device Manufacturers Exclusive Access to Global Panel of Experts in 3 Key Cities
10. Endexx Secures Exclusive World Wide Rights for Medical Marijuana Dispensing Technology
11. PatientStream Announces Industry Top Performer, Tom McLaren, to Lead an Exclusive Education Webinar on Surgical Efficiency to 300+ hospitals nationwide.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... --  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... the ralinepag phase 2 trial.  Ralinepag is an oral, ... the treatment of pulmonary arterial hypertension (PAH). The study ... "This marks an important step in the development of ... our pipeline," said Amit Munshi , Arena,s President ...
(Date:12/7/2016)... , Dec. 7, 2016   TraceLink Inc ... for connecting the Life Sciences supply chain and ... today announced that Tjoapack has selected TraceLink,s serialization ... customers comply with the rapidly approaching serialization deadlines ... (DSCSA) in 2017 and the EU Falsified Medicines ...
(Date:12/7/2016)... ZIONA SCIENCE PARK , ... biotechnology company Kadimastem (TASE: KDST) announced today the signing of a ... collaboration between the companies. The synergy between the companies will assist ... collaboration as a worldwide leader in innovative treatment for severe diseases ... ...
Breaking Medicine Technology:
(Date:12/7/2016)... TX (PRWEB) , ... December 07, 2016 , ... ... 2016 Top 20 Marketing Campaign Winner in the Folio: Marketing Awards competition. Live ... recognize the year’s best in pioneering, inventive, and ultimately successful projects undertaken by ...
(Date:12/7/2016)... Scottsdale, AZ (PRWEB) , ... ... ... pioneer, ElectroMedical Technologies, announced its newest portable bioelectronic medicine device WellnessPro Plus ... , WellnessPro Plus substantially enhances the WellnessPro platform by expanding the treatment ...
(Date:12/7/2016)... ... 2016 , ... “Walking With God: Inspirational Lessons from My Life's Journey”: ... be aware of God's direction in their lives. “Walking With God: Inspirational Lessons from ... active church leader. , Sanford says, “I enjoy sharing the true stories ...
(Date:12/7/2016)... ... December 07, 2016 , ... Dr. Greg Leyer, the ... Probiotic Association’s Washington DC workshop on November 2nd. The conference was an opportunity ... probiotic dietary supplement regulations. , Dr. Leyer spoke about two main topics ...
(Date:12/6/2016)... ... 2016 , ... The International Vaccine Institute (IVI) and GeneOne ... Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The collaboration will accelerate MERS-CoV vaccine development ... in the event of a future outbreak. , IVI and GeneOne held a ...
Breaking Medicine News(10 mins):